Ribavirin‐Associated Hemoglobinuria with Treatment of Hepatitis C Virus Infection | Zendy

Catherine Diamond | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ribavirin‐Associated Hemoglobinuria with Treatment of Hepatitis C Virus Infection

Author(s) -

Catherine Diamond

Publication year - 2004

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/382700

Subject(s) - ribavirin , medicine , hepatitis c virus , hematologic disorders , adverse effect , hemoglobinuria , virology , hepatitis c , immunology , hepatitis , virus , hemolysis

SIR-I am writing in response to the article by Dietrich and Spivak [1] entitled "Hematologic Disorders Associated with Hepatitis C Virus Infection and Their Management." Recently, I treated a patient with a hematologic adverse event-hemoglobinuria-that was caused by ribavirin therapy administered for hepatitis C virus (HCV) infection. Because Dietrich and Spivak [1] did not mention this adverse effect in their review article, I wish to describe such a case.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research